Sale of Cal Enters Final Stretch as Antitrust Ruling Looms
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
By חזי שטרנליכט
What happened
Cal’s sale to Union Group and Harel Investments is awaiting a final antitrust ruling expected in the coming days. The key obstacle is possible overlap involving Shufersal’s card program, Be pharmacy chain, and Union’s stake in Super-Pharm. If the deal fails for regulatory reasons, the buyers must compensate Bank Discount.
- 01Antitrust chief Michal Cohen is expected to decide Cal’s sale within days.
- 02Union Group and Harel want to buy Cal from Discount and First International Bank.
- 03Regulators are focused on Shufersal’s card club, Be, and Union’s stake in Super-Pharm.
- 04The deal was valued at up to 4 billion shekels and has been repeatedly delayed.
- 05If the deal collapses over approvals, the buyers owe Discount compensation.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Ask About This Story
Duki reads it, and every newsroom on the same story, then answers with sources.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
